Mottola Frank bought SUPN
February 28, 2026 · Form 4 insider transaction
Mottola Frank bought 3,750 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
3,750
Price
$0.00
Total value
N/A
InsiderMottola Frank
Role—
SecurityPerformance Share Unit
Transaction codeA: Grant or award
Transaction dateFebruary 28, 2026
Filing dateMarch 3, 2026
Shares owned after3,750
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023.